News | SCCT | July 25, 2023

HeartFlow, Inc. to Announce New Data on Diagnosing and Managing Coronary Artery Disease at the 2023 Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting

HeartFlow announced that new data on HeartFlow Plaque Analysis and its RoadMap Analysis will be presented at the 2023 Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Boston, MA.

July 25, 2023 — HeartFlow, Inc., the only non-invasive precision coronary care solution to provide both anatomic and physiologic insights, announced that new data on HeartFlow Plaque Analysis and its RoadMap Analysis will be presented at the 2023 Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Boston, MA. 

“The data being presented at SCCT are the latest findings in a robust body of evidence that show HeartFlow technologies help clinicians further improve diagnostic accuracy and clinical decision-making to ensure the right patients are getting the right care at the right time,” said Campbell Rogers, Chief Medical Officer of HeartFlow. “Our continued investment in research underscores not only our culture of innovation but also our unwavering commitment to quality in order to develop best-in-class products to support physicians and the patients they treat.” 

Details of the poster presentations are as follows: 

  • Title: “Primary Results Of The REVEALPLAQUE Study: A Prospective Quantitative Assessment Of AI-based CCTA Plaque Volume Compared With IVUS”; Date and Time: July 28, 9:30-10:15 AM EDT (Session 8); Speaker: Jagat Narula, M.D.; UTHealth Houston; Location: Exhibit Hall (Hynes Convention Center)
  • Title: “Utility Of AI Plaque Quantification: Results Of The Decisions For Treating Coronary Disease Are Changed In Patients Evaluated With Quantified Plaque Analysis (DECODE) Study”; Date and Time: July 28, 9:30-10:15 AM EDT (Session 8); Speaker: Sarah Rinehart, M.D. Charleston Area Medical Center; Location: Exhibit Hall (Hynes Convention Center)
  • Title: “A Study To Measure the Ability of the RoadMap Analysis to Support CCTA Reading Efficiency, Confidence, and Reproducibility (SMART-CT)”; Date and Time: July 29, 9:40-10:30 AM EDT (Session 10); Speaker: Michael Morris, M.D., Banner Health; Location: Exhibit Hall (Hynes Convention Center)
  • Title: Comparison of AI-based CCTA Interpretation and QCA for Coronary Stenosis Evaluation “(RoadMap Accuracy)”; Date and Time: July 29, 9:40-10:30 AM EDT (Session 10); Speaker: James Dundas, M.D., University of British Columbia and St Paul’s Hospital, Vancouver, British Columbia, Canada; Location: Exhibit Hall (Hynes Convention Center) 

Heartflow is also hosting a symposium on Friday, July 28, 7:00-7:50 AM ET in Room 312. Featured speakers include Jonathon Leipsic, M.D., FSCCT, former president of SCCT; Jagat Narula, M.D., PhD, MACC, Executive Vice President and Chief Academic Officer at UTHealth Houston; Wesley O’Neal, M.D., MPH, FACC, Director, Cardiac CT and Nuclear Cardiology at Cone Health Heart & Vascular Center and Sarah Rinehart, M.D., FACC, FSCCT, Director of Cardiac Imaging, Director of Cardiology Fellowship at Charleston Area Medical Center. Company representatives will also be available during the conference at Booth 207.

For more information: www.heartflow.com 

Find more SCCT23 conference coverage here


Additional Content

News | Cardiac Imaging

Nov. 1, 2026 — GE HealthCare recently introduced Allia Celeo,* a ceiling-mounted image guiding system, at the ...

Home November 05, 2026
Home
News | Cardiac Imaging

Nov. 2, 2026 – Conavi Medical Corp. has announced the completion of the first U.S. placement and clinical cases with ...

Home November 03, 2026
Home
News | Cardiac Imaging

Oct. 6, 2026 — Riverain Technologies has announced that its FDA-cleared ClearRead Chest suite will be available through ...

Home October 08, 2026
Home
News | Cardiac Imaging

Aug. 12, 2026 — Salus Scientific has launched its Clinical Insights Series, a new publication platform designed to share ...

Home August 17, 2026
Home
News | Cardiac Imaging

Aug. 12, 2026 — Ventripoint Diagnostics is expanding subscription-based access to its VMS+ 4.0, its FDA-cleared platform ...

Home August 14, 2026
Home
Subscribe Now